Only a select few labs can currently test for Zika and a commercial test would improve the ability of researchers to track the disease’s spread. Ten biotech companies and 10 other companies are at various stages of developing such a test, according to WHO.
“New validated and broadly available diagnostics are urgently needed to step up research, clinical management and surveillance,” said Marie-Paule Kieny, WHO assistant director-general, at a press conference. “Although it is difficult to predict the time for the first commercial and independently validated tests to be available, we are talking weeks and not years.”
Researchers are also developing a Zika vaccine, but they are at least 18 months away, according to Kieny.
- Who Will Be TIME's Person of the Year 2023?
- Why Cell Phone Reception Is Getting Worse
- The Dirty Secrets of Alternative Plastics
- Column: It's Time to Scrap the Abraham Accords
- Israeli Family Celebrates Release of Hostage Grandmother
- In a New Movie, Beyoncé Finds Freedom
- The Top 100 Photos of 2023
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time